arrow
Back
H

Heinz Gisslinger

Medical University of Vienna

76H-index
514Paper Count
2.7WCitation Count
Published Papers 108
Publication Date
Thromboembolism and bleeding in newly diagnosed Multiple Myeloma – Rates, risk profile and patterns of thromboprophylaxis
err2025-08-26
err0
errOAAI
errLea Vospernik; Hermine Agis; Cihan Ay; Lina Rüsing; Heinz Gisslinger; Christina Brunbauer; Clara Sophie Michel; Ingrid Simonitsch-Klupp; Alexandra Kaider; Maria-Theresa Krauth; Julia Riedl
errShare
errSave
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera
err2025-08-06
err0
errOAAI
errTiziano Barbui; Arianna Ghirardi; Victoria Empson; Francesca Fenili; Giuseppe Gaetano Loscocco; Annalisa Condorelli; Alessandra Iurlo; Daniele Cattaneo; Elena Rossi; Valerio De Stefano; Paola Guglielmelli; Christoph Klade; Heinz Gisslinger; Alessandro Rambaldi; Joseph M. Scandura; Alessandro Maria Vannucchi
errShare
errSave
Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study
err2025-07-29
err0
errOAAI
errLina Zoe Rüsing; Jakob Schweighofer; Julia Aschauer; Georg Jeryczynski; Lea Vospernik; Heinz Gisslinger; Armin Marcus Bumberger; Julia Cserna; Julia Riedl; Hermine Agis; Maria-Theresa Krauth
errShare
errSave
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia
err2025-07-26
err0
PREAI
errTiziano Barbui; Jürgen Thiele; Arianna Ghirardi; Hans Michael Kvasnicka; Umberto Gianelli; Daniel A. Arber; Heinz Gisslinger; Alessandro M. Vannucchi; Attilio Orazi; Ayalew Tefferi
errShare
errSave
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
errLEUKEMIA
IF13.4
err2023-08-26
err25
errOAAI
errGisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Empson, Victoria; Hasselbalch, Hans C.; Kralovics, Robert; Kiladjian, Jean-Jacques; PROUD-PV Study Grp
errShare
errSave
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms
err2023-03-09
err4
errOAAI
errIvanov, Daniel; Milosevic Feenstra, Jelena D.; Sadovnik, Irina; Herrmann, Harald; Peter, Barbara; Willmann, Michael; Greiner, Georg; Slavnitsch, Katharina; Hadzijusufovic, Emir; Ruelicke, Thomas; Dahlhoff, Maik; Hoermann, Gregor; Machherndl-Spandl, Sigrid; Eisenwort, Gregor; Fillitz, Michael; Sliwa, Thamer; Krauth, Maria-Theresa; Bettelheim, Peter; Sperr, Wolfgang R.; Koller, Elisabeth; Pfeilstoecker, Michael; Gisslinger, Heinz; Keil, Felix; Kralovics, Robert; Valent, Peter
errShare
errSave
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 x 109/L to < 100 x 109/L) at baseline: the final analysis of EXPAND
err2022-09-10
err9
errOAAI
errGuglielmelli, Paola; Kiladjian, Jean-Jacques; Vannucchi, Alessandro M.; Duan, Minghui; Meng, Haitao; Pan, Ling; He, Guangsheng; Verstovsek, Srdan; Boyer, Francoise; Barraco, Fiorenza; Niederwieser, Dietger; Pungolino, Ester; Liberati, Anna Marina; Harrison, Claire; Roussou, Pantelia; Wroclawska, Monika; Karumanchi, Divyadeep; Sinclair, Karen; Te Boekhorst, Peter A. W.; Gisslinger, Heinz
errShare
errSave
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
errLEUKEMIA
IF13.4
err2022-02-24
err58
errOAAI
errKiladjian, Jean-Jacques; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Empson, Victoria; Hasselbalch, Hans C.; Kralovics, Robert; Gisslinger, Heinz
errShare
errSave
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
err2022-01-21
err14
errOAAI
errMilosevic Feenstra, Jelena D.; Jaeger, Roland; Schischlik, Fiorella; Ivanov, Daniel; Eisenwort, Gregor; Rumi, Elisa; Schuster, Michael; Gisslinger, Bettina; Machherndl-Spandl, Sigrid; Bettelheim, Peter; Krauth, Maria-Theresa; Keil, Felix; Bock, Christoph; Cazzola, Mario; Gisslinger, Heinz; Kralovics, Robert; Valent, Peter
errShare
errSave
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
errLEUKEMIA
IF13.4
err2021-05-20
err39
errOAAI
errCervantes, Francisco; Ross, David M.; Radinoff, Atanas; Palandri, Francesca; Myasnikov, Alexandr; Vannucchi, Alessandro M.; Zachee, Pierre; Gisslinger, Heinz; Komatsu, Norio; Foltz, Lynda; Mannelli, Francesco; Passamonti, Francesco; Gilotti, Geralyn; Sadek, Islam; Tiwari, Ranjan; Zor, Evren; Al-Ali, Haifa Kathrin
errShare
errSave
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups
err2020-10-20
err5
errOAAI
errGisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Rossiev, Viktor; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Hasselbalch, Hans C.; Kralovics, Robert; Kiladjian, Jean-Jacques
errShare
errSave
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
errLEUKEMIA
IF13.4
err2020-08-07
err8
errOAAI
errChowdhury, Onima; O'Sullivan, Jennifer; Barkas, Nikolaos; Wang, Guanlin; Buck, Gemma; Hamblin, Angela; Tefferi, Ayalew; Al-Ali, Haifa K.; Barosi, Giovanni; Devos, Timothy; Gisslinger, Heinz; Jiang, Qian; Kiladjian, Jean-Jacques; Mesa, Ruben; Passamonti, Francesco; Ribrag, Vincent; Schiller, Gary; Vannucchi, Alessandro M.; Zhou, Daobin; McMullin, Mary Frances; Zhong, Jianhua; Gale, Robert Peter; Mead, Adam J.
errShare
errSave
Imbalance between plasma double-stranded DNA and deoxyribonuclease activity predicts mortality after out-of-hospital cardiac arrest
err2020-06-01
err10
PREAI
errOndracek, A. S.; Hofbauer, T. M.; Wurm, R.; Arfsten, H.; Seidl, V.; Frueh, A.; Seidel, S.; Hubner, P.; Mangold, A.; Goliasch, G.; Heinz, G.; Lang, I. M.; Sterz, F.; Adlbrecht, C.; Distelmaier, K.
errShare
errSave
Increased resting heart rate and prognosis in treatment-naive unselected cancer patients: results from a prospective observational study
err2020-03-23
err25
errOAAI
errAnker, Markus S.; Frey, Maria K.; Goliasch, Georg; Bartko, Philipp E.; Prausmueller, Suriya; Gisslinger, Heinz; Kornek, Gabriela; Strunk, Guido; Raderer, Markus; Zielinski, Christoph; Huelsmann, Martin; Pavo, Noemi
errShare
errSave
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
err2020-03-01
err232
errOAAI
errGisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Rossiev, Viktor; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Grohmann-Izay, Barbara; Hasselbalch, Hans C.; Kralovics, Robert; Kiladjian, Jean-Jacques
errShare
errSave
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
err2019-11-29
err57
errOAAI
errSant'Antonio, Emanuela; Guglielmelli, Paola; Pieri, Lisa; Primignani, Massimo; Randi, Maria Luigia; Santarossa, Claudia; Rumi, Elisa; Cervantes, Francisco; Delaini, Federica; Carobbio, Alessandra; Betti, Silvia; Rossi, Elena; Lavi, Noa; Harrison, Claire N.; Curto-Garcia, Natalia; Gisslinger, Heinz; Gisslinger, Bettina; Specchia, Giorgina; Ricco, Alessandra; Vianelli, Nicola; Polverelli, Nicola; Koren-Michowitz, Maya; Ruggeri, Marco; Girodon, Francois; Ellis, Martin; Lurlo, Alessandra; Mannelli, Francesco; Mannelli, Lara; Sordi, Benedetta; Loscocco, Giuseppe Gaetano; Cazzola, Mario; De Stefano, Valerio; Barbui, Tiziano; Tefferi, Ayalew; Vannucchi, Alessandro Maria
errShare
errSave
GDF-15 in solid vs non-solid treatment-naive malignancies
err2019-09-26
err13
errOAAI
errArfsten, Henrike; Cho, Anna; Freitag, Claudia; Raderer, Markus; Goliasch, Georg; Bartko, Philipp E.; Wurm, Raphael; Strunk, Guido; Gisslinger, Heinz; Marosi, Christine; Kornek, Gabriela; Zielinski, Christoph; Huelsmann, Martin; Pavo, Noemi
errShare
errSave
Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis
err2019-05-09
err24
errOAAI
errDurrant, Simon T.; Nagler, Arnon; Guglielmelli, Paola; Lavie, David; le Coutre, Philipp; Gisslinger, Heinz; Chuah, Charles; Maffioli, Margherita; Bharathy, Savita; Dong, Tuochuan; Wroclawska, Monika; Martinez Lopez, Joaquin
errShare
errSave
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-nave cancer patients
err2019-02-22
err16
errOAAI
errPavo, Noemi; Arfsten, Henrike; Cho, Anna; Goliasch, Georg; Bartko, Philipp E.; Wurm, Raphael; Freitag, Claudia; Gisslinger, Heinz; Kornek, Gabriela; Strunk, Guido; Raderer, Markus; Zielinski, Christoph; Huelsmann, Martin
errShare
errSave
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis
err2018-11-15
err38
errOAAI
errVannucchi, Alessandro M.; te Boekhorst, Peter A. W.; Harrison, Claire N.; He, Guangsheng; Caramella, Marianna; Niederwieser, Dietger; Boyer-Perrard, Francoise; Duan, Minghui; Francillard, Nathalie; Molloy, Betty; Wroclawska, Monika; Gisslinger, Heinz
errShare
errSave